Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis

Annals of Tropical Medicine and Parasitology

Volumn 91, Issue 6, 1997, Pages 611-616

  Thakur, C P ^a,b   Narain, S ^a   Kumar, N ^a   Hassan, S M ^a   Jha, D K ^a   Kumar, A ^a  

^a Kala azar Research Centre   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIMONY GLUCONATE; ANTIPARASITIC AGENT; CREATININE;

ADOLESCENT; ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG COST; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INDIA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEISHMANIASIS; NEPHROTOXICITY; RELAPSE; SHIVERING; SKIN LEISHMANIASIS; ST SEGMENT;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0030828290     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034989760707     Document Type: Article

References (31)

1. ANON. (1991). Report of the Expert Committee. Kala-azar in Bihar. New Delhi: Director General of Health Services, Ministry of Health and Family Welfare.
2. BERMAN, J. D. & WYLER, D. J. (1980). An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. Journal of Infectious Diseases, 142, 83-86.
3. BRANCH, R. A. (1988). Prevention of amphotericin B induced renal impairment: a review on the use of sodium supplementation. Archives of Internal Medicine, 148, 2389-2394.
4. BUTLER, W. T., BENNET, J. E., ALLUS, D. W., WERTLAKE, P. T., UT, Z. J. P. & HILL, G. J. M. (1964). Nephrotoxicity of amphotericin B: early and late effects on 81 patients. Annals of Internal Medicine, 61, 175-187.
5. DUTTA, M. & GHOSH, T. K. (1983). Review of current status of leishmaniasis epidemiology. In Proceedings of the Indo-UK Workshop on Leishmaniasis, pp. 97-102. New Delhi: Indian Council of Medical Research.
6. EL-HASSAN, A. M., GHALIB, H. W., ZIJLSTRA, E. E., EL-TOUM, I. A., SATTI, M., ALI, M. S. & ALI, H. M. A. (1992). Post kala-azar dermal leishmaniasis in the Sudan. Clinical features, pathology and treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 245-246.
7. HASSIM, F. A., KHALIL, E. A., ISMAIL, A. & EL-HASSAN, A. M. (1995). Apparently successful treatment of two cases of post kala-azar dermal leishmaniasis with liposomal amphotericin B. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 440.
8. HOEPRICH, P. D. (1992). Clinical use of amphotericin B and derivatives: lore, mystique and fact. Clinical Infectious Diseases, 14 (Suppl. 1), 114-119.
9. JHA, T. K., GIRI, Y. N., SINGH, T. K. & JHA, S. (1995). Use of amphotericin B in drug resistant cases of visceral leishmaniasis in North Bihar, India. American Journal of Tropical Medicine and Hygiene, 52, 536-538.
10. KAN, V. L., BENNET, J. E., AMANTEA, M. A., SMOLSKIS, M. C., MCMANUS, E., GRASELA, D. M. & SHERMAN, J. W. (1991). Comparative safety, tolerance and pharmacokinetics of amphotericin B lipid complex and amphotericin B deoxycholate in male volunteers. Journal of Infectious Diseases, 164, 418-421.
11. KHALIL, E. A., NUR, N. M., ZIJLSTRA, E. E., EL-HASSAN, A. M. & DAVIDSON, R. N. (1996). Failure of a combination of two antifungals, terbinafine plus itraconazole in Sudanese post kala-azar dermal leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 187-188.
12. KIRK, R. (1940). Studies in leishmaniasis in the Anglo-Egyptian Sudan. IV. A punctate rash in treated cases. Transactions of the Royal Society of Tropical Medicine and Hygiene, 34, 213-216.
13. MILLER, R. P. & BATES, J. H. (1969). Amphotericin B toxicity: a follow up report of 53 patients. Annals of Internal Medicine, 71, 1089-1095.
14. MISHRA, M., SINGH, M. P., CHAUDHARY, D., SINGH, U. P. & KHAN, A. B. (1991). Amphotericin B for second line treatment of Indian visceral leishmaniasis. Lancet, i, 926.
15. MUIGAI, R., GACHIHI, G. S., OSTER, C. N., WERE, J. H. O., NAYAKUNDI, P. M., CHUNGE, C. N., KIRIGI, G. M. & RASHID, R. (1991). Post kala-azar dermal leishmaniasis, the Kenyan experience. East African Medical Journal, 68, 801-806.
16. SEN GUPTA, P. C. (1960). Leishmaniasis. In A Handbook of Tropical Diseases, 6th Edn, eds Banerjee, J. C. & Bhattachariya, P. B. pp. 131-136. Calcutta: Academic.
17. SINGH, R. P. (1968). Observation on dermal leishmaniasis in Bihar. Indian Journal of Dermatology, 3, 1-5.
18. THAKUR, C. P. (1984). Epidemiological, clinical and therapeutic features of Bihar kala-azar including post kala-azar dermal leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 78, 391-398.
19. THAKUR, C. P. (1993). Diminishing effectiveness of currently used drugs in the treatment of kala-azar and amphotericin B in antimony and pentamidine resistant kala-azar. In Current Trends in Leishmania Research, eds Bhaduri, A. N., Basu, M. K., Sen, A. K. & Kumar S. pp. 254-262. New Delhi: Council of Scientific and Industrial Research.
20. THAKUR, C. P. (1995). Correction of serum electrolytes imbalance prevents cardiac arrhythmia during amphotericin B administration. National Medical Journal of India, 8, 13-14.
21. THAKUR, C. P. & KUMAR, K. (1990). Efficacy of prolonged therapy with sodium stibogluconate on post kala-azar dermal leishmaniasis. Indian Journal of Medical Research, 91, 144-148.
22. THAKUR, C. P. & KUMAR, K. (1992). Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Annals of Tropical Medicine and Parasitology, 86, 355-359.
23. THAKUR, C. P., KUMAR, K., SINHA, P. K. , MISHRA, B. N. & PANDEY, A. K. (1987). Treatment of post kala-azar dermal leishmaniasis with sodium stibogluconate. British Medical Journal, 295, 886-887.
24. THAKUR, C. P., SINHA, G. P., PANDEY, A. K., BARAT, D. & SINHA, P. K. (1993). Amphotericin B in resistant kala-azar in Bihar. National Medical Journal of India, 6, 57-60.
25. THAKUR, C. P., SINHA, G. P., BARAT, D. & SINGH, R. K. (1994). Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis? Annals of Tropical Medicine and Parasitology, 88, 365-370.
26. THAKUR, C. P., SINHA, G. P., BARAT, D. & SINGH, R. K. (1995). Two-hour versus six-hour administration of amphotericin B in the treatment of kala-azar. International Journal of Antimicrobial Agents, 5, 115-117.
27. THAKUR, C. P., SINHA, G. P. & PANDEY, A. K. (1996). Comparison of regimens of amphotericin B deoxycholate in kala-azar. Indian Journal of Medical Research, 103, 259-263.
28. WORLD HEALTH ORGANIZATION (1978). A Decade of Health Development in South-east Asia. South-east Asia Regional Publication Series No. 7. New Delhi: WHO.
29. WORLD HEALTH ORGANIZATION (1984). The Leishmaniases. Report of a WHO Expert Committee. Technical Report Series No. 701. Geneva: WHO.
30. WORLD HEALTH ORGANIZATION (1990). Control of the Leishmaniases. Technical Report Series No. 793. Geneva: WHO.
31. ZIJLSTRA, E. E., EL-HASSAN, A. M. & ISMAEL, A. (1995). Endemic kala-azar in eastern Sudan. Post kala-azar dermal leishmaniasis. American Journal of Tropical Medicine and Hygiene, 52, 299-305.